Currently Skimming:
5 The Roles of Professional Societies
5 The Roles of Professional Societies
Pages 41-48
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 41... ...
. BOX 5-1 Potential Contributions of Professional Societies and Other Organizations as Suggested by Individual Speakers • Self-regulation through accreditation and certification can be used to attain a professional commitment to meeting high standards of clini cal, laboratory, research, and marketing practices.
|
From page 42... ...
Though some have claimed that assisted reproductive technology is largely unregulated, the reality is otherwise, he said. At the federal level, the Centers for Disease Control and Prevention collects and publishes outcomes data on reproductive success rates and performs annual audits of about 10 percent of programs.
|
From page 43... ...
SART helps clinics remain compliant with government regulations, provides a donor-screening test and questionnaire, and has developed a standardized informed consent form describing the risks of assisted reproductive technology which also provides choices for the disposition of excess embryos in the event of death, divorce, or some other situation, Schattman said. An advertising committee monitors member websites and advertising.
|
From page 44... ...
THE INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH ISSCR, which is the largest professional organization of stem cell scientists, encourages responsible clinical translation through the education of scientists and medical practitioners on professional standards, said George Daley, Samuel E Lux IV Professor of Hematology/Oncology and director of the Pediatric Stem Cell Transplant Program at Children's Hospital, who was ISSCR president in 2007 and 2008.
|
From page 45... ...
THE INTERNATIONAL SOCIETY FOR CELLULAR THERAPY Today's marketing claims, whether for stem cells, progenitor cells, immune cells, or xenogeneic fetal cells, tend to be unsupported by the kind of scientific evidence needed to gain authorization from a regulatory
|
From page 46... ...
The taskforce's goals are to review the major scientific and ethical issues involved in cellular therapeutics, to review the state of the science regarding types of cells being used and their marketed indications, to develop effective communications strategies, to develop tools for patient decision making, and to serve as public advocates for the field. The ISCT taskforce has working groups on definitions, scientific evidence and biological rationale, laboratory cell processing, clinical practice, regulation, commercial implications, communications, and policy, Sipp said.
|
From page 47... ...
Building on a 2010 white paper on stem cell tourism (Gunter et al., 2010) , ISCT will be reaching out to other organizations and partners, including scientific societies, medical associations, industry groups, patient and disease advocacy groups, ethics organizations, and heath economic groups, to develop an effective communications strategy.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.